211 related articles for article (PubMed ID: 12134019)
1. Mutations that affect the tropism of DA and GDVII strains of Theiler's virus in vitro influence sialic acid binding and pathogenicity.
Jnaoui K; Minet M; Michiels T
J Virol; 2002 Aug; 76(16):8138-47. PubMed ID: 12134019
[TBL] [Abstract][Full Text] [Related]
2. The effect of Theiler's murine encephalomyelitis virus (TMEV) VP1 carboxyl region on the virus-induced central nervous system disease.
Senkowski A; Shim B; Roos RP
J Neurovirol; 1995 Mar; 1(1):101-10. PubMed ID: 9222346
[TBL] [Abstract][Full Text] [Related]
3. Role of sialyloligosaccharide binding in Theiler's virus persistence.
Zhou L; Lin X; Green TJ; Lipton HL; Luo M
J Virol; 1997 Dec; 71(12):9701-12. PubMed ID: 9371636
[TBL] [Abstract][Full Text] [Related]
4. Amino acid substitutions in VP2 residues contacting sialic acid in low-neurovirulence BeAn virus dramatically reduce viral binding and spread of infection.
Kumar AS; Kallio P; Luo M; Lipton HL
J Virol; 2003 Feb; 77(4):2709-16. PubMed ID: 12552011
[TBL] [Abstract][Full Text] [Related]
5. Theiler's murine encephalomyelitis virus attachment to the gastrointestinal tract is associated with sialic acid binding.
Tsunoda I; Libbey JE; Fujinami RS
J Neurovirol; 2009 Jan; 15(1):81-9. PubMed ID: 19115131
[TBL] [Abstract][Full Text] [Related]
6. A single amino acid change determines persistence of a chimeric Theiler's virus.
Jarousse N; Grant RA; Hogle JM; Zhang L; Senkowski A; Roos RP; Michiels T; Brahic M; McAllister A
J Virol; 1994 May; 68(5):3364-8. PubMed ID: 7512164
[TBL] [Abstract][Full Text] [Related]
7. Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B.
Tsunoda I; Wada Y; Libbey JE; Cannon TS; Whitby FG; Fujinami RS
J Virol; 2001 Aug; 75(16):7494-505. PubMed ID: 11462022
[TBL] [Abstract][Full Text] [Related]
8. The structure of a highly virulent Theiler's murine encephalomyelitis virus (GDVII) and implications for determinants of viral persistence.
Luo M; Toth KS; Zhou L; Pritchard A; Lipton HL
Virology; 1996 Jun; 220(1):246-50. PubMed ID: 8659122
[TBL] [Abstract][Full Text] [Related]
9. Analysis of cellular mutants resistant to Theiler's virus infection: differential infection of L929 cells by persistent and neurovirulent strains.
Jnaoui K; Michiels T
J Virol; 1999 Sep; 73(9):7248-54. PubMed ID: 10438812
[TBL] [Abstract][Full Text] [Related]
10. Differential usage of carbohydrate co-receptors influences cellular tropism of Theiler's murine encephalomyelitis virus infection of the central nervous system.
Lipton HL; Kumar AS; Hertzler S; Reddi HV
Glycoconj J; 2006 Feb; 23(1-2):39-49. PubMed ID: 16575521
[TBL] [Abstract][Full Text] [Related]
11. Sialylation of the host receptor may modulate entry of demyelinating persistent Theiler's virus.
Zhou L; Luo Y; Wu Y; Tsao J; Luo M
J Virol; 2000 Feb; 74(3):1477-85. PubMed ID: 10627559
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the leader and capsid coding regions of persistent and neurovirulent strains of Theiler's virus.
Michiels T; Jarousse N; Brahic M
Virology; 1995 Dec; 214(2):550-8. PubMed ID: 8553557
[TBL] [Abstract][Full Text] [Related]
13. Chimeric Theiler's virus with altered tropism for the central nervous system.
Jarousse N; Fiette L; Grant RA; Hogle JM; McAllister A; Michiels T; Aubert C; Tangy F; Brahic M; Peña Rossi C
J Virol; 1994 May; 68(5):2781-6. PubMed ID: 8151749
[TBL] [Abstract][Full Text] [Related]
14. Low-neurovirulence Theiler's viruses use sialic acid moieties on N-linked oligosaccharide structures for attachment.
Shah AH; Lipton HL
Virology; 2002 Dec; 304(2):443-50. PubMed ID: 12504583
[TBL] [Abstract][Full Text] [Related]
15. Adaptation of Theiler's virus to L929 cells: mutations in the putative receptor binding site on the capsid map to neutralization sites and modulate viral persistence.
Jnaoui K; Michiels T
Virology; 1998 May; 244(2):397-404. PubMed ID: 9601508
[TBL] [Abstract][Full Text] [Related]
16. UDP-galactose transporter is required for Theiler's virus entry into mammalian cells.
Hertzler S; Kallio P; Lipton HL
Virology; 2001 Aug; 286(2):336-44. PubMed ID: 11485401
[TBL] [Abstract][Full Text] [Related]
17. Replacement of loop II of VP1 of the DA strain with loop II of the GDVII strain of Theiler's murine encephalomyelitis virus alters neurovirulence, viral persistence, and demyelination.
Wada Y; McCright IJ; Whitby FG; Tsunoda I; Fujinami RS
J Virol; 1998 Sep; 72(9):7557-62. PubMed ID: 9696853
[TBL] [Abstract][Full Text] [Related]
18. A neutralization site of DA strain of Theiler's murine encephalomyelitis virus important for disease phenotype.
Sato S; Zhang L; Kim J; Jakob J; Grant RA; Wollmann R; Roos RP
Virology; 1996 Dec; 226(2):327-37. PubMed ID: 8955052
[TBL] [Abstract][Full Text] [Related]
19. The CD4-mediated immune response is critical in determining the outcome of infection using Theiler's viruses with VP1 capsid protein point mutations.
Rodriguez M; Roos RP; McGavern D; Zoecklein L; Pavelko K; Sang H; Lin X
Virology; 2000 Sep; 275(1):9-19. PubMed ID: 11017783
[TBL] [Abstract][Full Text] [Related]
20. The neurovirulence of the DA and GDVII strains of Theiler's virus correlates with their ability To infect cultured neurons.
Jarousse N; Syan S; Martinat C; Brahic M
J Virol; 1998 Sep; 72(9):7213-20. PubMed ID: 9696815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
